eClinicalWorks — along with several of its executives and employees — agreed to pay $155 million in May to resolve allegations the company violated the False Claims Act. The government alleged eClinicalWorks withheld information from its certifying entity, including information as how its software reportedly wasn’t able to meet certain criteria for standardized drug codes, according to DOJ officials.
For the report, titled “eClinicalWorks 2017: Snapshot of Customer Reactions to the DOJ Settlement,” KLAS Research surveyed roughly 50 customers who had previously rated the EMR vendor to see if their satisfaction and attitude toward the company had changed.
Only 4 percent of customers said they plan to replace their EMR vendor due to the settlement. Twenty-four percent said they were overall dissatisfied and planning to replace the vendor, up from 20 percent of respondents prior to the settlement. Thirty-five percent of customers said they were still satisfied with eClinicalWorks and plan to keep the vendor, compared to 37 percent prior to the settlement.
More articles on health IT:
AI predicts schizophrenia with 74% accuracy, study finds
Report: 5 psychology insights into ransomware tactics
Rush University Medical Center taps Tempus to develop ‘biobank’
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.